Gilead Sciences
Trade Gilead Sciences 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About GILD
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases.
GILD Key Statistics
Stock Snapshot
Gilead Sciences(GILD) stock is priced at $124.22, giving the company a market capitalization of 154.25B. It carries a P/E multiple of 18.80 and pays a dividend yield of 2.6%.
On 2026-01-08, Gilead Sciences(GILD) stock moved within a range of $121.30 to $124.69. With shares now at $124.22, the stock is trading +2.4% above its intraday low and -0.4% below the session's peak.
Trading activity shows a volume of 6.18M, compared to an average daily volume of 4.27M.
The stock's 52-week range extends from a low of $88.57 to a high of $128.70.
The stock's 52-week range extends from a low of $88.57 to a high of $128.70.
GILD News
OncoNano Medicine recently announced a research collaboration with Gilead Sciences to test its ON-BOARD encapsulation technology with a Gilead drug candidate, w...
UBS analyst Michael Yee maintained a Buy rating on Gilead Sciences yesterday and set a price target of $145.00. Claim 70% Off TipRanks Premium Unlock hedge fund...
Advertisement Why Gilead Sciences is on investors’ radar today Gilead Sciences (GILD) has been drawing attention after recent share moves, with the stock clos...
Analyst ratings
76%
of 29 ratingsMore GILD News
In the latest market close, Gilead Sciences (GILD) reached $72.41, with a -0.21% movement compared to the previous day. The stock fell short of the S&P 500, whi...
Claim 70% Off TipRanks This Holiday Season Repare Therapeutics ( (RPTX) ) has issued an announcement. Repare Therapeutics has entered into an asset purchase a...